For Research Use Only
Tirzepatide 20mg
Lyophilized peptide • Not for human or veterinary use
Tirzepatide is a research peptide classified as a dual GIP and GLP-1 receptor agonist.
It is investigated for its potential effects on glucose regulation, insulin sensitivity,
and energy balance. Research models explore its ability to influence metabolic pathways related
to appetite control, lipid oxidation, and glucose homeostasis.
Key Research Points
- Dual GIP and GLP-1 receptor agonist peptide
- Explored for effects on metabolic and glucose regulation
- May influence lipid metabolism and energy utilization
- Studied for potential body composition and appetite modulation mechanisms
Form
Lyophilized Powder
Content
20mg per vial
Appearance
White to off-white lyophilized powder
Storage
Refrigerate 2–8°C or store below 25°C dry
Disclaimer: For laboratory research use only. Not approved for human or veterinary use, ingestion, or medical applications.
Reconstitute using sterile technique under controlled laboratory conditions.
Reconstitute using sterile technique under controlled laboratory conditions.
